Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma
Why the incidence of skin cancer increased in Central Europe and preventative measures
Cell cycle-dependent resistance or sensitivity to drugs and the importance of MITF genes in melanoma
How imaging techniques used to assess response in skin cancer are changing
Marius Erik Mayerhöfer
What support can doctors provide patients in terms of pyschological well-being?
The use of mouse models in melanoma with brain metastases to test new therapies
BRIM-3 trial in melanoma: prognostic factors of overall survival and the issue of salvage therapies